Patent details

Basic Information

Publication number:

EP2173349

PCT Application Number:

PCT/FR/2008/000943

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP088278262

PCT Publication Number:

WO/2009/024667

First applicant's nationality:

Translation Language:

EPO Publication Language:

French

English Title of Invention:

ANTITUMOUR COMBINATIONS CONTAINING A VEGF INHIBITING AGENT AND IRINOTECAN

French Title of Invention:

COMBINAISONS ANTITUMORALES CONTENANT UN AGENT INHIBITEUR DE VEGF ET DE L'IRINOTECAN

German Title of Invention:

ANTITUMOR-KOMBINATIONEN MIT EINEM VEGF-HEMMENDEN MITTEL UND IRINOTECAN

SPC Number:

Dates

Filing date:

02/07/2008

Grant date:

09/03/2011

EP Publication Date:

09/03/2011

PCT Publication Date:

26/02/2009

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

14/04/2010

EP B1 Publication Date:

09/03/2011

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

02/07/2020

Expiration date:

02/07/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

02/07/2008

 

 

Name:

Aventis Pharma S.A.

Address:

20, avenue Raymond Aron, 92160 Antony, France (FR)

Inventor

1

Name:

CHIRON-BLONDEL Marielle

Address:

France (FR)

2

Name:

BISSERY Marie-Christine

Address:

France (FR)

3

Name:

VRIGNAUD Patricia

Address:

France (FR)

4

Name:

LEJEUNE Pascale

Address:

France (FR)

Priority

Priority Number:

0704868

Priority Date:

05/07/2007

Priority Country:

France (FR)

Classification

Main IPC Class:

A61K 31/4745;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

24/06/2019

Last Annual Fee Paid Number:

12

Last Annual Fee Paid Amount:

165 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages